The Role of Impaired Mitochondrial Dynamics in MFN2-Mediated Pathology M Zaman, TE Shutt Frontiers in Cell and Developmental Biology 10, 2022 | 47 | 2022 |
Characterization of a novel variant in the HR1 domain of MFN2 in a patient with ataxia, optic atrophy and sensorineural hearing loss G Sharma, M Zaman, R Sabouny, M Joel, K Martens, D Martino, ... F1000Research 10, 2021 | 15 | 2021 |
Valosin-Containing Protein (VCP): A Review of Its Diverse Molecular Functions and Clinical Phenotypes CS Pontifex, M Zaman, RD Fanganiello, TE Shutt, G Pfeffer International Journal of Molecular Sciences 25 (11), 5633, 2024 | 1 | 2024 |
The Ketogenic Diet Metabolite β-Hydroxybutyrate Promotes Mitochondrial Elongation via Deacetylation and Improves Autism-like Behavior in Zebrafish GM Uddin, R Lacroix, M Zaman, IA Khatib, JM Rho, DM Kurrasch, ... bioRxiv, 2022.10. 03.510695, 2022 | 1 | 2022 |
The MFN2 Q367H variant from a patient with late-onset distal myopathy reveals a novel pathomechanism connected to mtDNA-mediated inflammation M Zaman, G Sharma, W Almutawa, TGB Soule, R Sabouny, M Joel, ... medRxiv, 2024.06. 20.24309123, 2024 | | 2024 |
A novel variant in MFN2 linked to a lethal disorder of neonatal onset M Zaman, J Mercadier, AV Tyndall, B McInnes, AM Innes, FP Bernier, ... medRxiv, 2024.09. 05.24313021, 2024 | | 2024 |
Pharmacologic Activation of Integrated Stress Response Kinases Inhibits Pathologic Mitochondrial Fragmentation KR Baron, S Oviedo, S Krasny, M Zaman, R Aldakhlallah, P Mathur, ... bioRxiv, 2024.06. 10.598126, 2024 | | 2024 |
Characterization of a novel variant in the HR1 domain of MFN2 in a patient with ataxia, optic atrophy and sensorineural hearing loss [version 2; peer review: 2 approved G Sharma, M Zaman, R Sabouny, M Joel, K Martens, D Martino, ... F1000research 10, 2021 | | 2021 |